Efficacy of sodium alginate as an endoscopic submucosal injectant during endoscopic submucosal dissection.

Efficacy of sodium alginate as an endoscopic submucosal injectant during endoscopic submucosal dissection. - Efficacy of sodium alginate as an endoscopic submucosal injectant during endoscopic submucosal dissection.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009000

Enrollment

Registered

2012-09-28

Start date

2011-11-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastric cancer

Interventions

sodium alginate as an endoscopic submucosal injectant during endoscopic submucosal dissection.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Early gastric cancer which can be treated by endoscopic submucosal dissection according to third edition of Japanese gastric cancer treatment guidelines 2010.

Exclusion criteria

Exclusion criteria: Case with lymph node metastasis or distant metastasis.

Design outcomes

Primary

Measure	Time frame
Adverse event	—

Secondary

Measure	Time frame
operation time, en bloc resection rate, recurrence rate, complication, pathological curative resection rate, healing process of gastric ulcer due to endoscopic submucosal dissection, laboratory data	—

Countries

Japan

Contacts

Public ContactToru Kusano

Oita University Faculty of Medicine Department of Gastroenterological Surgery

kusanot@oita-u.ac.jp097-586-5843

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026